Literature DB >> 12960016

Does thyrotropin cleave its cognate receptor?

Gregorio D Chazenbalk1, Chun-Rong Chen, Sandra M McLachlan, Basil Rapoport.   

Abstract

A recent report of major pathophysiological significance, and opposed to present concepts, is that TSH (but not MS-1, a hamster monoclonal thyroid-stimulating antibody), cleaves the single-chain TSH receptor (TSHR) on the cell surface into its two-subunit form. We reassessed the issue using two approaches. First we wished to confirm the flow-cytometric assay previously used to quantitate TSHR cleavage. We used CHO cell lines expressing large (TSHR-10,000 cells) or conventional (TSHR-0 cells) numbers of TSHR. Cells were preincubated (16 h) in either control medium or medium supplemented with TSH (5 x 10(-8) m) or MS-1 (10 microg/ml). After stringent washing to maximize removal of residual ligand, we performed flow cytometry with two antibodies, one recognizing only the single-chain TSHR, the other recognizing all (cleaved and uncleaved) TSHRs. TSH pretreatment did not appear to increase TSHR cleavage. Instead we observed ligand occupancy of the TSHR (with MS-1) or fewer receptors on the cell surface (down-regulation), particularly with the TSHR-0 cells. Second, we covalently cross-linked [125I]TSH to monolayers of these cells, an unequivocal method to determine directly the proportion of single-chain and two-subunit TSHR forms. Pretreatment of TSHR-10,000 and TSHR-0 cells with TSH had no effect on the degree of TSHR cleavage. MS-1 slightly reduced spontaneous cleavage. In conclusion, in contrast to a recent report, we show that TSH does not alter the subunit structure of its cognate receptor, and we provide insight into the difficulties associated with the flow-cytometric assay for TSHR cleavage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960016     DOI: 10.1210/en.2003-1002

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavage.

Authors:  Anna E Hakalahti; Miia M Vierimaa; Minna K Lilja; Esa-Pekka Kumpula; Jussi T Tuusa; Ulla E Petäjä-Repo
Journal:  J Biol Chem       Date:  2010-06-29       Impact factor: 5.157

Review 2.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

Review 3.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-01-22       Impact factor: 19.871

4.  Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.

Authors:  Sepehr Hamidi; Chun-Rong Chen; Ramachandran Murali; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2012-11-26       Impact factor: 4.736

Review 5.  Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.

Authors:  Gunnar Kleinau; Catherine L Worth; Annika Kreuchwig; Heike Biebermann; Patrick Marcinkowski; Patrick Scheerer; Gerd Krause
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

6.  TSH Combined with TSHR Aggravates Diabetic Peripheral Neuropathy by Promoting Oxidative Stress and Apoptosis in Schwann Cells.

Authors:  Jingwen Fan; Qi Pan; Qun Gao; Wenqing Li; Fei Xiao; Lixin Guo
Journal:  Oxid Med Cell Longev       Date:  2021-11-11       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.